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CHAPTER I 
Introduction 
Human serum albumin (HSA) is the most abundant protein in the blood plasma 
and it is capable of binding to a range of hydrophobic metabolites e.g. fatty acids, metal 
ions including Cu(II), Zn(II) and Co(II), drugs and exogenous/endogenous compounds 
[1]. The remarkable binding properties of albumin play central role in both in efficacy 
and the rate of drug delivery [2]. The binding properties of drug to HSA is an important 
factor determining their pharmacokinetics. HSA often increases the apparent solubility 
of hydrophobic drugs in plasma and modulates their delivery to the cells in vivo and in 
vitro [3,4], thereby playing a dommant role in drug disposition and efficacy. 
Reversible binding to Human Serum protein modulates the distribution of drugs 
and then affects the pharmacokinetic and pharmacodynamic properties. Once 
administered, the free concentration of a drug can change due to endogenous factors and 
its interaction with other drugs/binding to plasma proteins or due to some significant 
changes of serum carrier concentration [5, 6]. 
A study of HSA-drug interaction elucidates the mechanism of drug protein 
interaction at molecular level [7]. Metal-based drugs constitute a new class of 
pharmaceuticals, a subject of extensive research in the area of inorganic medicinal 
chemistry for many chronic ailments viz cancer, diabetes and neurodegenerative diseases. 
The interaction of metallopharmecuticals with serum protein is an important aspect of 
metal-based drug metabolism, capable of strongly affecting the drug distribution and 
biotransformation, and ultimately the mechanism of action of the chemotherapeutic 
agents. 
In recent review, [8] advantages of HSA binding were displayed for medicinal 
inorganic applications. For example, HSA-metal ion binding effects include delaying 
systemic clearance, and prevention of redox conversion. Thereby, HSA-binding of 
gadolinium-based pharmaceutical was used to increase the residence time of gadolinium 
in blood, ensuring adequate time for enhanced MRl contrast [9]. Serum protein binding 
especially HSA-vanadyl binding was shown to delay systemic clearance of diabetic drug 
bis (maltolate) oxovanadium (IV) and also for inhibition of redox conversion of vanadyl 
to vanadate species. 
Human serum albumin (HSA) is a large globular protein with a concentration of 
0.65mM in blood plasma [10]. The crystallographic analysis of HSA revealed that the 
protein has 585 amino acid residue monomers, contains three homologous a-helical 
domains (I-III)[3.4,11 j , (Table-1)[ 12] and a single tryptophan (Trp-214). 
Distribution 
No. of atoms 
Whole 
molecule 
578 
Domain 
1 II 
192 187 
III 
199 
Subdomain 
lA IB IIA 
103 89 101 
IIB IIIAIIIB 
86 114 84 
Table 1. Distribution of amino acid residue in different domain of human serum albumin 
(HSA). 
Many drugs viz cisplatin, paclitaxal, anthracycline and other bioactive small 
molecules bind reversibly to HSA [13], implicating its role as carrier protein. The 
principal regions of ligand binding site of serum albumin are located in hydrophobic 
cavity in subdomain IIA and IIIA and location have been determined by crystallography 
for several ligands and drugs [14]. The metal binding occurs near tryptophan residue in 
the IIA subdomain and it is the primary binding site for many other drugs such as 
warfarin, cisplatin, 5-iodosalicyalic etc (Figure 1). 
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Figure 1. The environment of binding site in HSA as obtained directly from X-ray 
refinement. Distance in A " 
The interaction between metal based drugs with serum albumin and their transfer 
have been studied in detail by various biophysical techniques [15] viz UV-Vis titration, 
fluorescence spectroscopy, circular dichroism and cyclic voltammetry. The current focus 
of all these studies is to understand how these metal-based inorganic/ organometallic 
complexes could match and pharmacologically interact with protein targets. The serum 
protein acts as selective drug carrier because of their accumulation in tumor tissue. The 
drug pharmacology and efficacy are greatly influenced, therefore the interaction of HSA 
with antitumour drugs including anthracycline, paclitaxel and platinum drugs has been a 
subject of interest for many researchers in the area of chemical biology. 
L.T. Lemiesz and M. Luczkawski have demonstrated the competitive binding of 
cisplatin (cis-DDP)- the archtypical antitumor inorganic drug, paclitaxal (taxol) and 
andriamycin -a well-established antitumor drug with HSA [16] by employing UV-Vis, 
CD, fluorescence spectroscopy and inductively coupled plasma atomic emission 
spectroscopy ICP (AES) method. Since the drug usually administered intravenously and 
the protein binding may decrease the effective concentration of the free drug, which is 
responsible for their antitumor activity. Cisplatin is one of the most intensively used 
anitumor agents, however, its application in larger doses is limited by several toxic side 
effects. Although it is effective as a single chemotherapeutic drug, it has also been 
administered in combination with other drugs viz. multi-drug therapy [16], including 
taxoid cytotoxic agent (Paclitaxal), which may decrease the drug toxicity especially as 
induced by irreversible interaction of cisplatin with plasma protein 
Previous reports of cisplatin-HSA interaction reveal that there is a distinct 
variation in protein conformation including a considerable decrease of the helical 
structure and changes of HSA binding abilities towards other molecules [17]. Possible 
HSA binding site in cisplatin was suggested as Met-298 [18,19] forming (S, N) 
macrochelate (scheme 1). In taxol, HSA binding, there is potential unfolding of the 
protein structure suggesting non-specific binding and has been attributed to the presence 
of hydrogen bonding interaction between donor atom and taxol polar group [20]. Taxol 
molecule is bound in the vicinity of Trp-214, which is one of main drug binding cavity 
(site) in subdomain IIA [21]. The small change caused by adriamysin could be attributed 
to small conformational change induced in HSA molecule. 
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Scheme 1. Reaction of Cisplatin with human serum albumin 
Binuclear rhodium (11) complexes have aroused considerable interest due to their 
structure, reactivity and anticancer activity [22, 23, 24 25]. The coordination compound 
[Rh2X2(OOCR)2(N-N)2] and [Rh2(OOCR)2(N-N)2(H20)2]'^  (R=H, Me, PhCHOH, N-N= 
2,2'-bipyridine, 1,10-phenanthroline, and their derivatives) show cytostatic activity for 
human oral carcinoma KB cell line in vitro [26,27]. To obtain an insight into the 
molecular mode of action of intravenously administered anticancer metallated drugs, it is 
important to carry out their interaction studies with human serum protein. 
In another report L.T. Lemiesz and F.P.Pruchnik [28] carried out interaction of 
[Rh2(OAc)2(bpy)2(H20)2](OAc)2 with human serum albumin (HSA) by using Absorption 
titration, CD, Fluorescence and ICP methods. The interaction of 
[Rh2(OAc)2(bpy)2(H20)2](OAc)2 with HSA was followed through CD. 
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Figure 2. CD spectrum in the visible region of[Rh2(OAc)2(bpy)2(H20)2](OAc)2 -HSA 
at 10:1 molar ratio obtained after 24h of incubation at 37°C. 
Circular dichorism (CD) spectroscopy is an important technique, particularly 
suited to demonstrate the specific binding of small chromophoric complexes with 
transition in the visible region to the chiral biomolecules of high molecular weight [29]. 
The spectra of sample incubated with HSA showed characteristic CD transition in visible 
region. (Figure 2) while spectrum of [Rh2(OAc)2(bpy)2(H^)J(OAc)2 displayed positive 
transition at 390 and 450 nm, respectively. This indicates strong interaction between 
rhodium chromophore and the macromolecule of serum protein. CD spectra in the 
ultraviolet region exhibit two negative bands at 208 and 222 nm, which are characteristic 
of HSA. The binding of rhodium complexes considerably decreases both of these bands 
although they are similar in shape (Figure 3). 
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Figure 3. ^ UV CD spectra in the 200-250 nm range of HSA (1) and 
[Rh2(OAc)2(bpy)2(H20)2](OAc)2 -HSA (2) for the molar ratio of 10:1 in phosphate 
buffer. pH 7.4 containing 0.1 MNaCl. B: Fluorescence spectral change of HSA (—) and 
HSA incubated with Rh complex for molar ratio of 1:1 for 24h at 37°C (-—). 
Fluorescence measurements were performed to obtain the information about the 
structurally perturbed HSA. In these complexes, tryptophan fluorescence is the most 
frequently examined among the three intrinsic aromatic fluorophore in HSA molecule to 
obtain information about conformational change. When a HSA molecule was excited at 
298nm, a fluorescence intensity around 350nm reflects change in microenvironment of 
tryptophan residue [30] (FigureB) since the fluorescence intensity in the presence of 
rhodium metal complex was reduced 20% in comparison to native HSA suggestive of the 
unfolding of the tryptophan proximity of the protein closely related to the rhodium 
binding [28]. 
These reports clearly indicate that [Rh2(OAc)2(bpy)2(H20)2](OAc)2 binds 
effectively to serum albumin, with HSA causing a conformational change with the loss of 
helix stability of protein, a local perturbation of the binding site on the HSA molecule. 
Cyclic voltammetry (CV) is the most effective and versatile electroanalytical 
technique available for the mechanistic study of redox system. The obtained results from 
the redox properties of drug and biomolecule might have profound effect on our 
understanding of their in vivo redox behavior or pharmaceutical activity [31, 32, and 33]. 
Some metabolites can be differentiated from the parent compound. Since metabolism 
often proceeds through the addition or the modification of a substituent, and this will give 
rise to additional wave or to a shift of main wave [34]. 
The cyclic voltammogram of thorin solution on addition of HSA exhibit the peak 
current which decreased apparently without the change of peak potential suggesting that 
HSA could interact with thorin to form a supramolecular complex [35]. Li et al. had 
studied the competitive adsorption effect of many electroactive small molecules such as 
9, 10-anthraquinone, rutin, tetra phenyl porphyrin tetra sulphonate (TPPS) with 
biomolecules such as hemoglobin, albumin and antibody on the mercury dropping 
electrode [36, 37, 38]. 
Interaction of Cu (II) complexes with HSA was studied by cyclic voltammetric 
measurement in phosphate buffer. On interaction of Cu (II) complexes with HSA, there is 
shift in Ep value of-0.799 to 0.54 V at the same scan rate. Although the results indicate 
that the binding of HSA with Cu (II) complex has taken place but as the shift in formal 
potential of complex was not so significant, therefore it was inferred that the Cu (II) 
complex exhibits reduced binding for albumin [13]. 
Present Work 
Benzimidazoie derivatives have been extensively studied as potential therapeutic 
agents [39] because the benzimidazoie residue is a constituent of vitamin B12 [40,41,42]. 
Benzimidazoie, sometimes called 1, 3-dideazapurine and its derivatives can serve as 
model compound for purine due to the structural similarity. Benzimidazoie substituted 
derivatives show pronounced biological properties; they are useful for inhibiting cell 
proliferation, in the treatment of cancer. Besides this, Bis-benzimidazole has potent 
activity against a number of microorganisms including those that lead to AIDS-related 
infection [43]. 
Co (II) metal ion is biologically significant owing to the fact that it is present in 
vitamin B12 metalloprotein and it is capable to hydrolyse phosphodiester bond of the 
nucleic acid. Besides this, cobah containing complexes offer an exciting possibility for 
oral delivery of a wide variety of peptide based drugs -most efficient chemotherapeutics. 
Currently, these peptide based drugs are given intravenously because of digestion 
degradation and poor absorption. They covalently bind to the cobalt containing 
coenzyme. Vitamin B12 is readily transported from the digestive system for circulation 
[44]. 
In this work, an attempt has been made to synthesize mercaptobenzimidazole 
designed macrocycle and its Co (II) complex 1. Interaction studies of 1 were carried out 
with HSA employing biophysical techniques viz UV-Vis titration, steady-state 
fluorescence studies, cyclic voltammetry and circular dichoric measurements. 
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Experimental 
CHAPTER II 
CHAPTER II 
EXPERIMENTAL METHODS 
The following techniques were employed: 
1. Characterization techniques 
1.1 Infrared spectroscopy 
1.2 Ultra-violet and visible spectroscopy 
1.3 Nuclear magnetic resonance spectroscopy 
1.4 Electron paramagnetic resonance spectroscopy 
1.5 Mass spectroscopy 
1.6 Molar conductance measurements 
2. HSA binding studies 
2.1 Cyclic voltammetry 
2.2 Absorption spectral studies 
2.3 Fluorescence spectral studies 
2.4 Circular dichoric spectral studies 
1. Characterization techniques 
1.1 Infrared spectroscopy 
The infrared spectroscopy is a useful technique to characterize a compound. It 
results from transition between vibrational and rotational energy levels. IR region of the 
electromagnetic spectrum covers a wide range of wavelength from 200 to 4000 cm" . It 
has been found that in IR absorption, some of the vibrational frequencies are associated 
with specific groups of atoms and remain same irrespective of the molecules in which the 
group is present. These are called characteristic frequencies [45] and their constancy 
results from the constancy of bond force constants from molecule to molecule. The 
important observation that the IR spectrum of a complex molecule consists of 
characteristic group frequencies makes IR spectroscopy, unique and powerfiil tool in 
structural analysis. 
r 
1.2 Ultraviolet and visible spectroscopy 
When a molecule absorbs radiation, its energy is increased. This increased energy 
is equal to the energy of the incident photon expressed by the relation 
E = hv 
E =hc/?L 
where h is Planck's constant, v is the frequency, A, is the wavelength of the radiation and 
c is the velocity of light. Most of the compounds absorb light in the spectral region 
between 200 and 800 nm resulting in the excitation of electrons of the molecules from 
12 
ground state to higher electronic states. In transition metals, all the five 'd' orbitals viz. 
dxy, dyz, dxz, dz"^  and dx^ -y^  are degenerate. However, in coordination compounds due to the 
presence of ligands, this degeneracy is destroyed and d orbitals split into two groups tjg 
(dxy, dyz and dxz) and Cg (dz^  and dx^ .y^ ) in an octahedral complex and t and e in a 
tetrahedral complex. The set of t2g orbitals goes below the original level of degenerate 
orbitals in octahedral complexes and the case is reversed in tetrahedral complexes (Figure 
4,5). At energy higher than the ligand field absorption bands. 
Free ion 
• • . V - l -
,,(. 
Hypothetical ion 
in a spherically 
syminethc field 
''.vr <<« ''.i: 
Octahedral 
field 
IOO4 
'2« 
60v 
4O4 
Figure 4. Splitting of the d energy levels in an octahedral complex 
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\ 
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ADq 
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dDq 
d.i dxi-y2 
Figure 5. Ligand field splitting of a tetrahedral complex, 'g'subscript is omitted in Td 
Symmetry. 
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We commonly observe one or more very intense bands that go off scale unless log 
£ is plotted. These arc the charge transfer bands, corresponding to electron transfer 
processes that might be either ligand —» metal (L -* M) or metal -* ligand (M -^ L). 
M —^  L transitions occur for metal ion complexes that have filled, or nearly filled, t2g 
orbitals with ligands that have low lying empty orbitals. These empty orbitals are ligand 
%* orbitals in complexes such as those of pyridine, bipyridine, 1,10-phenanthroline, CN~, 
CO and NO. Figure 6 shows overlap of a t2g metal orbital and it* of CO. 
Ni — CSSQ! N i = C = = 0 
Valence bond representation 
(a) (b) 
Molecular orbital 
represenialion 
, M 
Figure 6. Metal carbon double bonding 
The L —»^  M charge-transfer (C-T) spectra have been studied more thoroughly. 
The intense bands are for Laporte-allowed transitions commonly of the p (ligand) —• d 
(metal) type. The ionization energy for the ligand (or its ease of oxidation) as well as the 
oxidation state and electronic configuration of the metal (or its ease of reduction) 
determines the energy of the transition. No net oxidation-reduction usually occurs, 
because of the short lifetime of the excited state [46]. 
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1.3 Nuclear magnetic resonance spectroscopy 
The nuclei of certain isotopes possess a mechanical spin or angular momentum. 
The NMR spectroscopy is concerned with nuclei having nuclear spin quantum number 
I = 1/2, example of which include ' H , '^C, ^ 'P , "'Sn and '^F. 
For a nucleus with I = 1/2, there are two values for the nuclear spin angular 
momentum quantum number mi = ±1/2 which are degenerate in the absence of a 
magnetic field. However, in the presence of the magnetic field, this degeneracy is 
destroyed such that the positive value of mi corresponds to the lower energy state and 
negative value to higher energy state separated by AE. 
In an NMR experiment, one applies strong homogeneous magnetic field causing 
the nuclei to presses. Radiation of energy comparable to AE is then imposed with radio 
frequency transmitter equal to precision or Larmor frequency and the two are said to be 
in resonance. The energy can be transferred from the source to the sample. The NMR 
signal is obtained when a nucleus is excited from low energy to high-energy state. 
1.4 Electron paramagnetic resonance spectroscopy 
EPR spectroscopy [47] is the branch of absorption spectroscopy in which 
radiation-having frequency in the microwave region is absorbed by energy levels of 
electrons with unpaired spins. The magnetic energy splitting is done by applying a static 
magnetic field. For an electron of spin S = 1/2, the spin angular momentum quantum 
15 
number will have values of ms = ±1/2. In absence of magnetic field, the two values of ms 
i.e. +1/2 and -1/2 will give rise to a doubly degenerate spin energy state. If a magnetic 
field is applied, this degeneracy is lifted and leads to the non-degenerate energy levels. 
The low energy level will have the spin magnetic moment aligned with the field and 
correspond to the quantum number m., = -1/2. On the other hand, the high energy state 
will have the spin magnetic moment opposed to the licld and correspond to the quantum 
number ms = +1/2. 
1.5 Mass spectroscopy 
At electron beam energy of about 9 to 15 electron volts, depending on the 
molecule involved, a molecular ion is formed by interaction with the beam of electrons. 
Recognition of the parent ion (actually a radical ion) is of great importance because it 
gives the molecular weight of the sample [48]. At this point, the molecular weight is an 
exact nymerical molecular weight not the approximation obtained by the all other 
molecular weight procedures. Mass spectra is usually obtained at an electron beam 
energy of 70 electron volts and under these conditions numerous fragment ions (including 
the parent ions) versus their relative concentrations constitutes the mass spectrum of the 
samples. The fragmentations occur on the basis of mass/charge (m/z). The largest peak in 
the spectrum is called base peak and assigned a value of 100%. The other peaks are 
reported as percentage of the base peak. 
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1.6 Conductance measurements 
The conductivity measurement is one of the simplest and easily available 
techniques used to study the nature of the complexes. It gives direct information 
regarding whether a given compound is ionic or covalent. For this purpose, the 
measurement of molar conductance (Am), which is related to the conductance value in the 
following manner, 
cell constant x conductance 
An,= 
Concentration of solute expressed in mol cm' 
Conventionally, solutions of 1x10'^  M strength are used for the conductance 
measurements. Molar conductance values of different types of electrolytes in a few 
solvents are given as, 1:1 electrolyte has a value of 80-115 ohm' cm^ mol"' in MeOH, 
65-90 ohm' cm^ mol"' in DMF, 78-80, 50-70 ohm' cm^ mol"' DMSO and 35-45 ohm"' 
cm^ mol"' in EtOH [49- 50]. Similarly, a solution of 2:1 electrolyte has a value of 160-
220 ohm"' cm^ mol"' in MeOH, 130-170 ohm"' cm^ mol"' in DMF and 70-90 ohm' cm^ 
mol"' in EtOH. 
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2. HSA binding studies 
HSA was procured from Sigma Chemical Company. All the experiments 
involving interaction of the complexes with HSA were conducted in phosphate buffer 
(0.1 M) adjusted to pH 7.0. The HSA was dissolved in phosphate buffer and was dialyzed 
against the same buffer overnight. Solutions of HSA gave UV absorbance at 280 nm. 
HSA concentration was determined by absorption spectroscopy using the molar 
o 
absorption coefficient 5.3 dm^ mol* cm"' at 280 nm. The stock solution was stored at 4 C. 
2.1 Cyclic voltammetry 
Cyclic voltammetry involves the measurement of current-voltage curves under 
diffusion controlled, mass transfer conditions at a stationary electrode, utilizing 
symmetrical triangular scan rates ranging from a few millivolts per second to hundred 
volts per second. The triangle returns at the same speed and permits the display of a 
complete polarogram with cathodic (reduction) and anodic (oxidation) waveforms one 
above the other. Two seconds or less is required to record a complete polarogram [51 ]. 
Consider the reaction 
O + ne' • R (i) 
Assuming semi-infinite linear diffusion and a solution containing initially only 
species O. With the electron held at a potential E, where no electrode reaction occurs. 
The potential is swept linearly at v v/sec so that the potential at any time is 
E(t) = Ei-vt 
or Cpeak - !•:"-0.0285 
The rate of electron transfer is so rapid at the electrode surface that species O and 
R immediately adjust to the ratio according to the Nemst equation, which is as follows., 
Co(0,t) = Co*-[nFA(7rDo)'T J I(n)(t-t)-"'dx (ii) 
1 = nFACo*(:tDoa)"^ X (a t) (iii) 
Redox (electron-transfer) reactions of metal complexes can be investigated by 
cyclic voltammetry. An electrode is immersed in a solution of the complex and voltage is 
swept while current flow is monitored. No current flows until oxidation or reduction 
occurs. After the voltage is swept over a set range in one direction, the direction is 
reversed and swept back to the original potential. The cycle may be repeated as often as 
desired. Figure 7 shows the cyclic voltammograms (CV) for a reversible one-electron 
redox reaction such as, 
CpFe(CO)LMe • CpFe(CO)LMe^ + e^  
Sweeping the potential in an increasing direction oxidize the complex as the 
anodic current la flows; reversible reduction of CpFe(CO)LMe'^  generates cathodic 
current Ic on the reverse sweep. The magnitude of the current is proportional to the 
concentration of the species being oxidized or reduced. 
The parameters of interest are Ipa/lpc the ratio of peak currents, Epa - Epc the 
separation of peak potentials and the formal electrode potential E'^ . For a Nemstian wave 
with stable product, the ratio Ipa/Ipc = 1 regardless of scan rate, E° and diffusion 
coefficient, when Ipa is measured from the decaying current as a base line. The difference 
between Epa and Epc (AEp) is a useful diagnostic test of a Nemstian reaction. Although 
AEp is slightly a function of E", it is always close to 2.3RT/ nF. 
f i r 
f 
( -1 
fc 
Figure 7. (a) Cyclic potential sweep (b) Resulting cyclic voltammogram 
The technique yields information about reaction reversibilities and also offers a 
rapid means of analysis for suitable systems. The method is particularly valuable to study 
interaction of metal ions to HSA as it provides a useful compliment to other methods of 
investigation, such as UV-vis spectroscopy. Cyclic voltammetric studies were 
accomplished on a CH Instrument Electrochemical analyzer using a three-electrode 
configuration comprised of a Pt wire as the auxiliary electrode, a platinum micro-cylinder 
as the working electrode and Ag/AgCl as the reference electrode. Supporting electrolyte 
for the experiments was 0.4 KNO3. Electrochemical measurements were made under 
nitrogen atmosphere. All electrochemical data were collected at 298 K and are 
uncorrected lor junction potentials. 
2.2 Absorption spectral studies 
In a closed constant volume system, the rate of a chemical reaction is defined as 
the rate of change of the concentration of any of the reactants and products with time. 
The concentration can be expressed in any units of quantity per unit volume e.g. moles 
per liter, moles per cubic centimeter. The rate will be defined as positive quantity 
regardless of the component whose concentration change is measured. 
The rate of a chemical reaction is not measured directly instead the concentration 
of one of the reactants or products is determined as a function of time. A common 
procedure for determining the reaction order is to compare the experimental results with 
integrated rate equations for reactions of different orders. For a first order rate equation, 
integrating by separate variables using integration limits such that at t = 0, c = CQ and at t 
= t, c = c. [52]. 
-dc/dt = kc 
or In (CQ/C) = kt 
The intrinsic binding constant Kb of the complex to HSA was determined from 
Eqn. (1), through a plot of [HSA]/ Sa-Sf vs. [HSA], where [HSA] represents the 
concentration of HSA, and Eg, er, and Sb the apparent extinction coefficient (Aobs /[M]), 
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the extinction coefficient for free metal complex (M), and tiie extinction coefficient for 
the free metal complex (M) in the fully bound form, respectively. In plots of [HSA]/£a-£f 
vs. [HSA], Kb is given by the ratio of slope to intercept [53]. These absorption spectral 
studies were performed on UV-1700 pharaspec UV-Vis spectrometer Shimadzu. 
FHSM = [HSA] ^ J (I) 
8a-8f Eb-Ef Kb(Eb-Ef) 
2.3 Fluorescence spectral studies 
HSA comprises a single polypeptide with 585 amino acids. In these amino acid, 
trptophan, tyrosine, phenylalanine are the only three intrinsic fluorophore. The intrinsic 
fluorescence of HSA is mainly contributed by tryptophan alone. When molecules that 
have absorbed light are in a higher electronic state, they must lose their excess energy to 
return back to the ground state. If the excited molecule returns to the ground state by 
emitting light, it exhibits fluorescence and spectrum thus obtained is called emission 
spectrum. This phenomenon is generally seen at moderate temperature in liquid solution. 
The emission spectra are obtained by setting the excitation monochromator at the 
maximum excitation wavelength and scanning with emission monochromator. Often an 
excitation spectrum is first made in order to confirm the identity of the substance and to 
select the optimum excitation wavelength. Further experiments were carried out to gain 
support for the mode of binding of complexes often is reacted with strong fiuorophores 
enabling them to be determined quantitatively. On this basis molecular fluorophore. 
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Quenching of the fluorescence of HSA were measured with increasing amount of metal 
complexes and Stem-Volmer quenching constant K was obtained from the following 
Eqn.[54] 
lo/I =1+Kr (2) 
Where r is the ratio of total concentration of complex to that of I ISA and lo and I arc the 
fluorescence intensities of HSA in the absence and presence of complex. Emission 
intensity measurements were carried out using Hitachi F-2500 spectrofluorometer at 
room temperature. 
2.4 Circular dichoric spectral studies 
Circularly polarized light represents a wave in which the electrical component 
spirals around the direction of propagation of the ray, either clockwise or 
counterclockwise. Within the absorption band, the molar absorptivity for right and left 
handed circularly polarized light is different, that is (ed-£i) i" 0. This effect changes 
linearly polarized light into elliptically polarized light and is known as circular dichroism. 
When a substance near an absorption band absorbs left circularly polarized light, the 1 
component, more strongly than the right circularly polarized light, the d component, i.e. 
El > 8d then the amplitude of d component will be greater than the 1 furthermore, if sj > si 
then the d component will be retarded more than the 1 component (Figure 8). 
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The ellipticity, that is the angle whose tangent is ratio of minor axis of the ellipse 
OB to the major axis OA, is denoted by G. The molecular ellipticity [0] can be shown by 
the relationship [55]. Circular dichroism graphs are plots of [G] against wavelength. 
[6] =3305(ei-£d) 
d component 
/ component 
Plane of 
incident beam -*^ 
I 
Figure 8. Elliplically polarized light produced when rjtj>rii andei>ed 
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M..eHa..„a physical ™««u„„e„. 
Cobalt chloride hexahydrate (C0CI2. 6H2O), oxalyl chloride, dibromo ethane (E. 
merk); Sodium dihydrogen phosphate, disodium hydrogen orthophosphate, Potassium 
carbonate (s.d. fine) and 2-mercaptobenzimida/olc (Sigma Aldrich) were used as 
received. Human Serum Albumin (HSA) was purchased from Sigma Chemical Co. All of 
the experiments involving interaction of complex with I ISA were performed in twice-
distilled phosphate buffer (O.IM) and pH was maintained as 7. Img/lml solution of HSA 
in phosphate buffer was prepared. 
Molar conductance at r. t. Digismum electronic Conductivity Bridge, UV-Vis 
titrations were performed on shimadzu 1700 Spectrophotometer in DMSO. CD studies 
were done on Jasco-J-715-CD Spectropolarimeter at room temperature. IR Spectra were 
taken on KBr pellets InterSpec -2020-FTIR Spectrometer. All 'H and '^ C spectra were 
recorded on 400 MHz Brucker Spectra -Spin Dl'X-FT-NMR and EPR spectra was 
recorded at Bucker-emx EPR Spectroscope 10/12-X band. Fluorescence titration 
experiments were taken at Hitachi F-2500 Fluorescence Spectrophotometer. 
All Voltammetric experiments were performed with a CH electrochemical 
analyzer, in a single compartmental cell at 25 °C with aqueous solution and 0.4M KNO3 
as supporting electrolyte at different scan rates. A three electrode configuration was used, 
with a Pt microcylinder as working electrode, a Pt wire as the auxiliary electrode and an 
Ag /AgCl electrode as the reference electrode. Electrochemical measurements were made 
under N2 atmosphere. 
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Syntheses 
Synthesis of (S, S'-bis (2-benziinidazolyl) 1,2-dithio oxalate] L| 
This ligand Li was synthesized according to the procedure reported earlier [56] 
and has been described below: 
To stirred slurry containing (1.5g, lOmMol) of 2-mercaptobenzimidazole and 
10ml anhydrous benzene, (0.634g, 5mMol) of oxalyl chloride was added dropwise at 50-
60 °C over a 15-niin period in 2:1 molar ratio. The stirred reaction mixture was heated at 
reflux for 5h. Atler cooling to 5°C, the solid was collected by filtration and air dried at 
25-30 °C. Yield 90%, mp 195-200 C°. Anal. Calcd. for C,6H,oN402S2: C, 54.22; H, 2.84; 
N, 15.81. Found C, 54.16; H, 2.81; N, 15.79. Selected IR data in KBr (v/cm'): broad 
3720-3120 (N-H); 1749 (str C=0); 2926 (Ar C-H str); 1540, 1513, 1470 (Ar C=C str); 
1263, 1168 (In plane C-ll bending); 744 (Ar =C-II out of plane bending); 419 (Ar out of 
plane C=C bending). 'H N M R (400MHZ, DMSO) ; 8 (ppm): 12.5(N-H); 7.09-7.15 (Ar-H). 
Synthesis of C36H24N8O4S4 L2 
The ligand Li (3.54g, lOmMol) dissolved in 10ml of CH3CN was treated with 1,2 
dibromoethane (1.87g, lOmMol), potassium carbonate (1.38g, lOmMol) and catalytic 
amount of KI stirred for 7h at room temperature. The cream white colored compound was 
filtered with buchner funnel washed with distilled water dried in vacuum. Yield 71%, mp 
270C'' Anal. Calcd. for C36H24N8O4S4(MW=760.80): C, 56.83; H, 3.18; N, 14.73; found 
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C, 56.34; H, 3.39; N, 14.36;. Selected IR data in KBr (v/cm'): 1745 (C=0 str); 3062, 
2955 (Ar C-H str); 2863 (CH2Str); 1653, 1478, 1395 (Ar C=C str); 1269, 1220 (In plane 
C-H bending); 748(Ar =C-H out of plane bending). 'H N M R (400MHZ, CDC13); 5(ppm): 
1.58 (-CH2); 7.5-8.48 (Ar-H). '^ C NMR (DMSO-dt, 400MHz); 5 (ppm): 168.12 (C=0), 
132.24, 122.31, 109.47 (Ar), and 39.92 (CH2). ESI (m/z^: 825 
[C36H24N8S404]^ +2MeOH 
Synthesis of C36 H24N8O4S4C0CI2 (1) 
The Co" complex was prepared by dissolving the ligand L2 (0.76g ImMol) in 
methanol 5ml. A methanolic solution of C0CI2.6H2O (0.23g ImMol) was added to the 
above ligand L2 solution and stirred for 3h. The cream colored solution turned to blue and 
finally blue colored solid product appeared. The complex was collected by filtration of 
the reaction mixture and washed with methanol. Dried under vacuum. Yield: 60% mp 
238C°. Anal. Calcd. for C36H24N8O4S4C0CI2: C, 48.54; H, 2.72; N, 12.58. Found C, 
48.34; H, 2.67; N, 11.98. Selected IR data in KBr (v/cm"'): 1690 (C=0); 2926 (Ar-H); 
2857(CH2 str); 1603, 1378(Ar C=C str); 744 (Ar -C-H out of plane bending). Molar 
Conductance ^M (1x10'^ DMSO); 17.0 O'cm^ Mol"', non-electrolyte. UV-Vis (1x10'^  
DMSO); Amax /nm 300; 606. 
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Synthetic Scheme 
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Results and Discussion 
CHAPTER III 
Results and Discussion: 
The synthesis of Co complex 1 was achieved by mixing stoichiometric amounts 
of Liand Cobalt (11) chloride in CH3OH. Molar conductance value of Complex in DMSO 
-] O 9 1 
(Ix 10 M) at 25 C suggests their non-electrolytic nature (17 Q cm Mol"). The 
coordination geometry of central metal ion is distorted octahedral confirmed by UV 
visible and EPR techniques. The ligand Li was prepared by adopting reported procedure 
[56]. L2 was synthesized by treating Li with 1, 2- Dibromoethane in presence of 
potassium carbonate (K2CO3) and catalytic amount of potassium iodide (KI) on stirring. 
The structure of Lzwas proposed on the basis of spectroscopic studies. Complex 1 was. 
Figure 9. Structure with minimum energy of complex (1) using MM2 program (Butterfly 
complex). 
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formed after complexation with C0CI2. Energy minimization of the butterfly structure of 
complex 1 has been done by using MM2 program (Figure 9). HSA binding studies were 
carried out with 1 and binding constant, mode of binding was determined. The interaction 
studies of 1 with human serum albumin indicate that 1 binds reversibly with it. 
IR Spectroscopy! 
The broad band around 3250 - 3149 cm"' was assigned to N-H and S-H stretching 
frequency suggesting at 2556 cm "' (in free 2- Mercaptobenzimidazole). As a 
consequence, the absence of S-H stretching band in 2600- 2500 cm' region and presence 
of C=0 stretching at 1749 cm' was signature of formation of Li. This was also 
confirmed by the display of N-H broad band in 3250 - 3149 cm' region in IR spectra. As 
a consequence, -C(0)-C(0)- moiety linked two 2- mercaptobenzimidazoles through 
sulphur atoms. L2 formation was revealed by absence of N-H broad band and -N-CH2-
CH2-N- bonding was supported by the appearance of bands at 2863 and 2746 cm' i.e. 
CH2 symmetric and asymmetric stretching. The medium intensity band at 748 cm"' due to 
plane =C-H binding and aromatic skeletal C -C band region (1601- 1395 cm "') support 
the aromatic ring. In IR spectrum of cobalt complex, there is a large negative shift of 
C=0 band 1745 to 1690 cm ' which revealed the complex formation. This prominent 
shift suggests that Co (II) ion is strongly coordinated with oxygen atoms. 
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NMR Spectroscopy: 
I I I 1 3 , Li and L2 were characterized by H, C NMR spectra recorded in CDCI3 and 
DMSO-de respectively and exhibited signals for aliphatic and aromatic protons with 
chemical shift values in accordance with proposed structure. The L| structure was 
confirmed by 12.5 ppm (NH) proton. The absence of signal at 11.0-13.0 ppm and 
presence of signal at 1.58 ppm due to CH2 proton confirmed the proposed structure of L2. 
The H ' NMR of L2 shows the resonance at 7.51, 7.82 and 8.46 ppm signatured the 
aromatic ring (Figure 10). The '^ C NMR spectrum of L2 was characterized by various 
resonance due to C=0 and CH2 at 168.12, 39.92, respectively in addition to the presence 
of aromatic carbons at 109.47, 122.31 and 132.24 ppm, respectively. 
j ? E | i P f ^ ? f i y 
Figure 10.'H NMR ofLi ligand 
'^ -A___._J'L 
0 5 ^ J 
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Electronic spectrum 
The UV-Vis spectra of 1 at room temperature in DMSO exhibited d-d transition 
absorption maxima centered at 556nm with extinction coefficient 58 M'crn' which is 
characteristic of six coordinated distorted octahedral complex [57, 58]. In addition, metal 
to ligand (MLCT) transition was observed at ?00 nm attributed to Co (II) -» n* of 
benzimidazole ring [59]. 
Electron paramagnetic resonance 
The electron paramagnetic resonance (EPR) spectrum of complex 1 was recorded 
at a frequency of 9.87 GHz under the magnetic field 3000±I000 gauss at room 
temperature. The complex 1 showed anisotropic spectra with different ga, gb and gc values 
i.e., 8.01, 2.20, and 1.66 respectively [60]. In complex 1, the next layer molecule is not 
exactly vertical but little distorted due to minimization of energy. The crystal does not 
seem to be orthorhombic but monoclinic or triclinic. The three different ga, gb and gc 
values indicate the distorted octahedral geometry around Co " metal ion. These results 
collaborate well with IJV-Visible studies and are suggestive of the distorted octahedral 
environment around Co(ll) metal ion . 
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Interaction studies of Complex 1 with HSA: 
Cyclic Voltammetry (CV): 
The electrochemical profile of 1 was studied in H2O/ DMSO (95:5) by cyclic 
voltammetry in the range from 0.4 to 0.8 V. The complex displayed a well-defined 
cathodic wave, but the corresponding anodic wave was drawn out revealing that very 
unstable Co (I) species are not discernible with the time scale of CV experiment. The 
cyclic voltammogram of 1 exhibited quasi-reversible one electron redox processing 
involving Co(ll) / Co(I) couple with cathodic peak at Epc =-0.41 V and oxidation peak Epa 
= -0.30 V. At different scan rates (Figure II) there is no major change in Epa and E1/2 
values, clearly indicating that Epa is independent of scan rate. For this couple, the 
difference between cathodic and anodic peak potential AEp and ratio of anodic and 
cathodic peak current Ipa / Ipc are -0.11 V and ~0.62 V, respectively. The formal electrode 
potential E1/2 taken as an average of Epc and Epa was -0.35 V in the absence of HSA. 
Addition of HSA to 1 results in significant reduction in cathodic and anodic peak current 
due to slow diffusion of an equilibrium mixture of free and HSA bound complex to the 
electrode surface [61, 62]. The observed shift in Epa and Epc value (Figure 12) indicate 
that Co(II) and Co(I) bind to HSA and show good binding affinity with HSA. 
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a 
1.6 1.4 12 1.0 0.8 O.e 0.4 0.2 0 -0.2 -0.4 -0.6 -0.8 
Pntf^ntial / V 
Figure 11. Cyclic voltammogram of complex 1 in DMSO/H2O (5:95) at different scan 
rates 0.1, 0.2, 0.3 Vs' 
< 
U 
1.4 1.2 1.0 0.8 0.6 0.4 0.2 0 -0,2 -0.4 -0.6 -O.l 
Potential / V 
Figure 12. Cyclic voltammogram of unbound complex 1(a) and complex 1 in presence of 
HSA (Ixia^ M) (b). 
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Steady - State Emission Titration 
HSA comprises a single polypeptide with 585 amino acids. Amongst them only 
three amino acids tryptophan, tyrosine and phenylalanine possess fluorophore. The 
intrinsic fluorescence of HSA is mainly contributed by tryptophan [63]. However 
tyrosine also contributes significantly to excitation wavelength 290 nm & emission 
wavelengths 295nm and emission intensity monitored at 340 nm and 300nm, respectively 
[64], Excitation slit width and emission slit width are 5nm and 10 nm, respectively. 
200 
300 350 
Wavelength(nrn) 
400 
Figure 13. Emission spectra of HSA in the presence of various concentration of complex 
1 (Xex=290 nm) 
Fixed amount of HSA was treated with increasing amount of complex 1. Over a 
range of complex 1 concentration from 0.066x10^ to 0.333x10"^M with different sets. 
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titration leads significant enhancement in fluorescence intensity at 300 nm and the 
emission band at 340 nm also display enhancement with bathochromic shift to lesser 
extent (Figure 13). The shift reflects that the microenvironment around the tryptophan in 
protein solution is quite different from pure aqueous phase. Addition of complex 1 to 
HSA can be rationalized in terms of binding of complex 1 with HSA which occurs near 
tryptophan residue in 11A subdomain leading to less polar microenvironment around 
tryptophan. The enhanced emission is maximum at tyrosine without change in the 
position indicates that microenvironment around fluorophore leading towards less 
polarity at large extent The relative fluorescence intensity of HSA with different 
concentrations of complex 1 as a function of complex /USA molar ratio was observed. 
The result suggest a reduction in binding capacity on increasing concentration of complex 
1 at the primary binding site of HSA IIA subdomain (Figure 14) [65]. 
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Figure 14. Relative fluorescence change treated with increasing concentration of 
complex 1 
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Absorption Titration: 
The absorption spectra of 1 in the absence and presence of MSA (at a constant 
concentration of complex 1.6 x 10'^  M) are depicted in Figure 15. The UV region of 
complex 1 exhibits metal to ligand charge transfer band at 300 nm attributed to Co (II) -^ 
n* of benzimidazole ring. On increasing concentration of USA from 0.03x10"^ to 
0.133x10' M, there is steep decrease in absorption intensity viz. hypochromism on 
increasing the concentration of USA, the absorbance value decreased further, which 
indicate that 1 interacts with HSA to form a complex [61]. However, no band shift was 
observed. The spectral evidence signature HSA binds to 1 but as absorption spectra 
recorded no shift in wavelength, reversible binding is more favoured. 
2.500 
0.000 
2 60.00 30a00 350.00 
Wavelength (nm) 
400.00 
Figure 15. Absorption Spectra of the complex 1 with decrease in absorption on stepwise 
increase of HSA. 
37 
0 2 
0 03 0.06 0 1 0 133 
11 ISA |N 10" 
0 166 
Figure 16. Plot offHSA]/ Sa - ^ vs. [HSA] for titration of complex 1 with HSA. 
In order to determine binding strengtii of 1 with USA, the intrinsic binding 
constant Kb of the complex was calculated with equation-1, by monitoring the change in 
absorbance with increasing concentration of HSA (Figure 16). The value of intrinsic 
binding constant Kb is given by slope to the intercept, the binding constant obtained for 1 
is 9.3 X 10'* M ' . The value of Kb suggests medium binding affinity for HSA. 
Circular dichoric studies 
The albumin structure is predominantly a-helical approximately, 67% of HSA is helical 
and the numbers of helices in the structure are 28 [66]. The complex -albumin interaction 
was monitored by the addion of complex 1 50pL (c IxlO'^M) to HSA solution as show in 
Figure 17. 
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CD spectra of HSA exhibit two negative bands in ultraviolet region at 208 and 
222nm characteristic for a a-hclical structure of protein. The binding of complex 1 to 
USA distinctly decreases the intensity of CD bands. I'his clearly indicates the reduction 
in its a-hclical structure up (o p-plcated sheet secondary structure |67, 68|. 
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Figure 17. CD spectral hands of HSA (—), spectral chanf^es of complex only (.....) and 
the effect of complex 1 on CD spectra of HSA (- - -), 
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Conclusions: 
The present endeavor is directed towards the design and synthesis of synthons 
based on mercapto benzimidazole moiety for generating specific molecular assemblies. 
The moiety can further cyclized through different linkers to generate designed 
macrocycle. L2 synthesized will be harbinger for making complexes, which has potential 
to be used pharmacologically active antitumor agents in the Held of cancer prolcomics. 
Binding studies of (1) with HSA carried out by employing UV-vis, CD, 
fluorescence spectroscopy and cyclic voltammetry techniques reveal weak reversible 
binding affinity with human serum albumin. These studies prove the usefulness of 
Complex 1 as a potential drug with reduced toxicity thereby, it warrants further in vitro/ 
in vivo antitumor studies and evaluation of pharmacokinetic parameters. 
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